Yang X, Dai YH, Peng H, Zhang MS, et al. Nab-paclitaxel plus cisplatin versus gemcitabine plus cisplatin as first-line treatment in advanced biliary tract cancer: results of a multicentre, randomised, phase II trial. BMC Cancer 2025;25:1321.
PMID: 40819029